Home›Stock Screener›Vivo Bio Tech›Quarterly Results

Vivo Bio Tech Quarterly Results

Latest Quarter Net Profit
₹1 Cr
QSept 2026
Quarterly Results

Vivo Bio Tech quarterly results. In Sept 2026, Vivo Bio Tech (VIVOBIOT) reported revenue ₹19 Cr and net profit ₹1 Cr — revenue +46.2% YoY. Also explore VIVOBIOT share price data to track price trends across different timeframes.

VIVOBIOT Quarterly Results — Revenue, Profit & EPS Highlights

Vivo Bio Tech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Vivo Bio Tech share price chart.

  • Revenue of ₹19 Cr in Sept 2026 (+35.7% vs Mar 2026, +46.2% vs Sept 2025)
  • Net Profit of ₹1 Cr in Sept 2026 (+120.0% vs Mar 2026, +0.0% vs Sept 2025)
  • EBITDA of ₹8 Cr in Sept 2026 (+60.0% vs Mar 2026)
  • Operating Margin of 35.0% in Sept 2026 (+4.0pp vs Mar 2026)
  • Earnings Per Share of ₹0.50 in Sept 2026 (+119.8% vs Mar 2026)

Vivo Bio Tech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VIVOBIOT quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 19 14 14 13 12 35.7% 46.2%
Net Profit (₹ Cr) 1 -5 0 1 1 - -
EBITDA (₹ Cr) 8 5 5 6 5 - -
EPS (₹) 0.50 -2.52 0.08 0.45 0.69 - -
Operating Margin (%) 35.0% 31.0% 35.0% 41.0% 41.0% - -

VIVOBIOT Share Price Trend — 1-Year Movement Across Quarterly Results

Vivo Bio Tech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View VIVOBIOT 52-week performance for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 5.3%
EBITDA Margin 42.1%
Operating Margin 35.0%
ROE (Annual) 4.3%

Balance Sheet Highlights

Total Assets ₹178 Cr
Total Equity ₹93 Cr
Current Assets ₹ Cr
Current Liabilities ₹55 Cr

Cash Flow Analysis

Operating Cash Flow ₹35 Cr
Investing Cash Flow ₹-59 Cr
Financing Cash Flow ₹25 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹14.32
Exchange NSE
Last Updated Nov 19, 2026

VIVOBIOT vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Vivo Bio Tech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores